InvestorsHub Logo
Followers 3
Posts 132
Boards Moderated 0
Alias Born 05/10/2011

Re: None

Thursday, 10/23/2014 1:10:22 PM

Thursday, October 23, 2014 1:10:22 PM

Post# of 27409
Biomaterials. 2014 Oct 4. pii: S0142-9612(14)01009-6. doi: 10.1016/j.biomaterials.2014.09.011. [Epub ahead of print]

Prediction of inflammatory responses induced by biomaterials in contact with human blood using protein fingerprint from plasma.

Engberg AE1, Nilsson PH2, Huang S3, Fromell K4, Hamad OA4, Mollnes TE5, Rosengren-Holmberg JP6, Sandholm K3, Teramura Y7, Nicholls IA8, Nilsson B4, Ekdahl KN9.


Author information

Abstract


Inappropriate complement activation is often responsible for incompatibility reactions that occur when biomaterials are used. Complement activation is therefore a criterion included in legislation regarding biomaterials testing. However, no consensus is yet available regarding appropriate complement-activation-related test parameters. We examined protein adsorption in plasma and complement activation/cytokine release in whole blood incubated with well-characterized polymers. Strong correlations were found between the ratio of C4 to its inhibitor C4BP and generation of 10 (mainly pro-inflammatory) cytokines, including IL-17, IFN-?, and IL-6. The levels of complement activation products correlated weakly (C3a) or not at all (C5a, sC5b-9), confirming their poor predictive values. We have demonstrated a direct correlation between downstream biological effects and the proteins initially adhering to an artificial surface after contact with blood. Consequently, we propose the C4/C4BP ratio as a robust, predictor of biocompatibility with superior specificity and sensitivity over the current gold standard.

Copyright © 2014 Elsevier Ltd. All rights reserved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News